# Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants

> **NCT02538458** · PHASE4 · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 120 (actual)

## Conditions studied

- Bronchiolitis

## Interventions

- **DRUG:** 3 % hypertonic saline up to 72H
- **DRUG:** 3 % hypertonic saline up to 24H

## Key facts

- **NCT ID:** NCT02538458
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538458, "Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02538458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*